Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Expensify (EXFY) EBT (2020 - 2025)

Expensify (EXFY) has disclosed EBT for 6 consecutive years, with -$3.5 million as the latest value for Q4 2025.

  • Quarterly EBT fell 4656.76% to -$3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.3 million through Dec 2025, down 580.86% year-over-year, with the annual reading at -$16.3 million for FY2025, 581.15% down from the prior year.
  • EBT hit -$3.5 million in Q4 2025 for Expensify, down from -$2.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $10.8 million in Q1 2021 to a low of -$21.4 million in Q4 2021.
  • Historically, EBT has averaged -$4.6 million across 5 years, with a median of -$3.8 million in 2023.
  • Biggest five-year swings in EBT: surged 102.72% in 2024 and later plummeted 22946.34% in 2025.
  • Year by year, EBT stood at -$21.4 million in 2021, then skyrocketed by 95.86% to -$885000.0 in 2022, then tumbled by 595.48% to -$6.2 million in 2023, then surged by 98.8% to -$74000.0 in 2024, then plummeted by 4656.76% to -$3.5 million in 2025.
  • Business Quant data shows EBT for EXFY at -$3.5 million in Q4 2025, -$2.2 million in Q3 2025, and -$9.4 million in Q2 2025.